False-positive PET/CT for lymphoma recurrence secondary to Langerhans cell histiocytosis.
Fotos, Joseph S; Flemming, Donald J; Tulchinsky, Mark.
Clin Nucl Med
; 36(8): 717-9, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21716031
Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients.
Surveillance scanning in lymphoma.
Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
Prognostic value of PET/CT in patients with lymphoma treated with autologous stem cell transplantation for relapsed/refractory or high risk disease.
Role of PET imaging in adaptive radiotherapy for lymphoma.
How do viruses trick B cells into becoming lymphomas?
Inflammatory myofibroblastic tumor mimicking lymphoma on <sup>18</sup>F-FDG PET/CT. Report of a case and review of the literature.
When should FDG-PET be used in the modern management of lymphoma?
FDG PET/CT imaging as a biomarker in lymphoma.